Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (Q24613764)

2

0 references

William A Richards

3

0 references

Brian D Richards

4

0 references

Una McCann

5

0 references

Robert Jesse

https://scigraph.springernature.com/pub.10.1007/s00213-011-2358-5

6

0 references

language of work or name

English

0 references

publication date

December 2011

0 references

published in

Psychopharmacology

0 references

volume

218

0 references

issue

4

0 references

page(s)

649-65

0 references

exact match

0 references

cites work

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Human hallucinogen research: guidelines for safety

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Experimental Psychiatry. V — Psilocybine, a New Psychotogenic Drug

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Some observations on psilocybin, a new hallucinogen, in volunteer subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Do hallucinogens cause residual neuropsychological toxicity?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

The psychopharmacology of hallucinogens

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Psychedelic drugs and mystical experience.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308357

Hallucinogens as medicine

30 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2358-5

Hallucinogenic Mushrooms in Mexico: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2358-5

Comparison of the reactions induced by psilocybin and LSD-25 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2358-5

REACTIONS TO PSILOCYBJN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2358-5

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2358-5

Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI)

21 January 2018

1 reference

12 December 2020

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

12 December 2020

Clinical, biochemical and psychologic effects of psilocybin

1 reference

12 December 2020

Comparison of psilocin with psilocybin, mescaline and LSD-25

1 reference

12 December 2020

THE EFFECT OF N,N-DIMETHYLTRYPTAMINE IN HUMAN SUBJECTS TOLERANT TO LYSERGIC ACID DIETHYLAMIDE

1 reference

12 December 2020

10.1007/S00213-011-2358-5

Identifiers

DOI

1 reference

Dimensions Publication ID

812202

1001926767

0 references

812202

1 reference

1 reference

1 reference